CCM
Camber Capital Management Portfolio holdings
AUM
$718M
1-Year Return
4.23%
This Quarter Return
+9.97%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.86B
AUM Growth
+$75.4M
(+2.7%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-6.24%
Top 10 Holdings %
Top 10 Hldgs %
66.68%
Holding
46
New
5
Increased
11
Reduced
9
Closed
8
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$83M |
| 2 |
Baxter International
BAX
|
$77.3M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$47M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$43M |
| 5 |
Medtronic
MDT
|
$28.8M |
Top Sells
| 1 |
Sanofi
SNY
|
$148M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$104M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$70.1M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$65.3M |
| 5 |
Dentsply Sirona
XRAY
|
$60.3M |
Sector Composition
| 1 | Healthcare | 96.89% |
| 2 | Consumer Staples | 1.45% |
| 3 | Consumer Discretionary | 0.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Moderna
MRNA
$9.44B
| $24.9M | 0.63% |
+250,000
| New | +$24.9M |
|
27
Harmony Biosciences
HRMY
$2.1B
| $24.2M | 0.62% |
+750,000
| New | +$24.2M |
|
28
Ascendis Pharma
ASND
$12.1B
| $20.8M | 0.53% |
+165,000
| New | +$20.8M |
|
|
BKDT
29
DELISTED
Brookdale Senior Living Inc. 7.00% Tangible Equity Units
BKDT
| $20.3M | 0.52% |
250,000
| – | – |
|
30
Puma Biotechnology
PBYI
$256M
| $12.1M | 0.31% |
2,805,000
-1,430,000
| -34% | -$6.19M |
|
31
Inogen
INGN
$220M
| $11M | 0.28% |
2,000,000
| – | – |
|
32
The Beauty Health Co
SKIN
$251M
| $10.9M | 0.28% |
3,500,000
-1,500,000
| -30% | -$4.67M |
|
33
Solid Biosciences
SLDB
$428M
| $8.71M | 0.22% |
1,418,439
| – | – |
|
34
Replimune Group
REPL
$452M
| $8.43M | 0.21% |
1,000,000
-1,000,000
| -50% | -$8.43M |
|
|
BCYC
35
Bicycle Therapeutics
BCYC
$477M
| $8.14M | 0.21% |
450,000
+50,000
| +13% | +$904K |
|
36
CureVac
CVAC
$1.21B
| $7.37M | 0.19% |
1,750,000
| – | – |
|
37
BioMarin Pharmaceuticals
BMRN
$10.9B
| – | – |
-300,000
| Closed | -$26.5M |
|
38
Exelixis
EXEL
$9.93B
| – | – |
-300,000
| Closed | -$6.56M |
|
39
Pfizer
PFE
$139B
| – | – |
0
| – | – |
|
40
Quanterix
QTRX
$202M
| – | – |
-1,275,000
| Closed | -$34.6M |
|
|
41
Sanofi
SNY
$111B
| – | – |
-2,750,000
| Closed | -$148M |
|
42
SPDR S&P 500 ETF Trust
SPY
$660B
| – | – |
0
| – | – |
|
|
43
Teva Pharmaceuticals
TEVA
$21.3B
| – | – |
-10,150,000
| Closed | -$104M |
|
|
44
Dentsply Sirona
XRAY
$2.84B
| – | – |
-1,765,000
| Closed | -$60.3M |
|
|
MRTX
45
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-1,500,000
| Closed | -$65.3M |
|
|
CANO
46
DELISTED
Cano Health, Inc.
CANO
| – | – |
-40,000
| Closed | -$1.01M |
|